Abbott India Limited
ABBOTINDIA
Rang in Aktien
#3029
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Aktienkurs
$285.88
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$6.07B
Veränderung (1 Tag)
-1.13%
Veränderung (1 Jahr)
-16.83%
Land
IN
Handel Abbott India Limited (ABBOTINDIA)
Kategorie
Healthcare
Gewinn für Abbott India Limited (ABBOTINDIA)
Gewinn im Jun 2026 TTM: $238.19M
Laut den aktuellen Finanzberichten von Abbott India Limited betragen die aktuellen Gewinne des Unternehmens $238.19M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $194.01M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $155.00M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Abbott India Limited von 2004 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $238.19M | 7.96% |
| 2025 | $220.63M | 13.72% |
| 2024 | $194.01M | 25.17% |
| 2023 | $155.00M | 8.97% |
| 2022 | $142.24M | 12.45% |
| 2021 | $126.49M | 18.71% |
| 2020 | $106.55M | 5.87% |
| 2019 | $100.64M | 5.44% |
| 2018 | $95.45M | 41.81% |
| 2017 | $67.31M | 12.04% |
| 2016 | $60.08M | 8.86% |
| 2015 | $55.19M | 39.00% |
| 2014 | $39.70M | 1.44% |
| 2012 | $39.14M | 15.33% |
| 2011 | $33.94M | 61.11% |
| 2010 | $21.06M | -16.67% |
| 2009 | $25.28M | 33.27% |
| 2008 | $18.97M | -26.36% |
| 2007 | $25.76M | 31.50% |
| 2006 | $19.59M | 3.19% |
| 2005 | $18.98M | -38.51% |
| 2004 | $30.87M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $33.60B | 14,004.37% |
US
|
|
| $17.74B | 7,346.49% |
US
|
|
| $8.70B | 3,552.08% |
US
|
|
| $5.95B | 2,397.14% |
US
|
|
| $21.39B | 8,879.40% |
CH
|
